Grand Rounds 2010-2011
Endocrinology Grand Rounds
2010-2011
Tuesdays 12:00-1:00 PM
Aurbach Building – 450 Ray C. Hunt Drive – Fontaine Research Park
First floor conference room
Date
Faculty
Topic
9/14/2010
Ken Saag, MD, MSc (University of Alabama at Birmingham)
Use of glucocorticoids in treatment: risks, benefits and choice of agents to prevent GIO
9/21/2010
E. Dale Abel, MD (University of Utah)
Novel insights into the cardiovascular consequences of insulin resistance
10/5/2010
Mark DeBoer, MD (Pediatric Endocrinology)
Endocrine sequelae of childhood cancer treatment
10/12/2010
Eugene Barrett, MD, PhD
Insulin resistance: how it is measured and what are the limitations
10/26/2010
Susanna Keller, MD
Rab GAPs and regulation of glucose homeostasis
11/2/2010
Michael Thorner, MBBS, DSc, FRCP, MACP
Is insulin resistance friend or foe?
11/9/2010
Sue Brown, MD
Denosumab: updates in osteoporosis treatment
11/16/2010
Ayotunde Dokun, MD, PhD
Nature and Nurture in the pathogenesis of peripheral arterial disease
11/30/2010
Robin Felder, PhD (Clinical Chemistry and Toxicology)
To salt or not to salt: the molecular basis of salt sensitivity
12/14/2010
Michael Sellix, PhD (Biology)
Gaining ground while gaining weight: understanding the role of the circadian clock in metabolic disease
12/21/2010
Shetal Padia, MD
Obesity-associated hypertension
1/11/2011
Helmy Siragy, MD
Is there an ideal treatment for hyponatremia?
1/25/2011
Erica Ungewitter, PhD (NIH, NIEHS)
Δ-40p53 controls IGF signaling and stem cell potency
2/1/2011
Mary Lee Vance, MD
Prolactinoma: diagnosis and treatment
2/22/2011
Adrian Halme, PhD (Cell Biology)
3/1/2011
Joyce Green-Pastors, RD, MS, CDE, & Terry Saunders, PhD
The use of standardized patient cases to teach diabetes clinical care skills to general medicine residents on Endocrine rotation
3/8/2011
William F. Young, Jr, MD, MSc, ELS (Mayo Clinic) (Crispell Lecture)
Pheochromocytoma: Tricks and Traps
3/15/2011
Farah Morgan, MD / Jennifer Kirby, MD, PhD
Metabolic consequences of HIV and its treatment (Morgan) / Osteoporosis in men: risk factors, screening, and treatment (Kirby)
3/22/2011
Eugene Barrett, MD, PhD
Cardiovascular disease and diabetes – when and how to intervene?
4/5/2011
Matthew Sauder, MD
From Greenland to New Zealand: exploring alternative therapies in endocrinology
4/12/2011
Ken Burman, MD (Washington Hospital Center)
Differentiated thyroid cancer: recent advances
4/19/2011
Kenneth Brayman, MD, PhD (Surgery)
Update on beta cell replacement therapy
4/26/2011
Darlene Berryman, PhD, RD (Ohio University)
Growth hormone and adipose tissue: it’s all in the depot
5/3/2011
Christopher McCartney, MD
Cross-sex hormone administration to persons with gender identity disorder: philosophical and practical dilemmas
5/10/2011
Jennifer Beller, MD / William Smith, MD
Premature ovarian failure: evaluation and treatment considerations (Beller) / Male infertility: and endocrinological perspective (Smith)
5/17/2011
Gregory Hong, MD, PhD / Jessicah Collins, MD
Sepsis and adrenal insufficiency: is it worth stressing over? (Hong) / Polycystic ovary syndrome and disordered sleep (Collins)
5/24/2011
Charles Upchurch, MD / Cristina Gherghe, MD, PhD
Microalbuminuria and cardiovascular outcomes (Upchurch) / Please don’t stress! (Gherghe)
5/31/2011
Rodney Snow, MD